Elkhorn Investments LLC acquired a new position in Cooper Companies Inc (NYSE:COO) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,266 shares of the medical device company’s stock, valued at approximately $1,283,000.
Several other institutional investors and hedge funds have also made changes to their positions in COO. Crossmark Global Holdings Inc. bought a new stake in shares of Cooper Companies in the 3rd quarter worth approximately $339,000. Canada Pension Plan Investment Board bought a new stake in shares of Cooper Companies in the 3rd quarter worth approximately $163,000. Prudential Financial Inc. lifted its holdings in shares of Cooper Companies by 1.8% in the 3rd quarter. Prudential Financial Inc. now owns 69,808 shares of the medical device company’s stock worth $16,552,000 after acquiring an additional 1,240 shares during the last quarter. CIBC Asset Management Inc raised its holdings in Cooper Companies by 8.6% during the 3rd quarter. CIBC Asset Management Inc now owns 5,101 shares of the medical device company’s stock valued at $1,209,000 after buying an additional 404 shares during the last quarter. Finally, New York State Common Retirement Fund raised its holdings in Cooper Companies by 0.5% during the 3rd quarter. New York State Common Retirement Fund now owns 226,107 shares of the medical device company’s stock valued at $53,612,000 after buying an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 98.55% of the company’s stock.
Shares of Cooper Companies Inc (NYSE COO) traded down $1.57 during midday trading on Wednesday, reaching $235.29. 33,275 shares of the company’s stock traded hands, compared to its average volume of 485,624. The company has a quick ratio of 1.61, a current ratio of 2.83 and a debt-to-equity ratio of 0.75. Cooper Companies Inc has a 1-year low of $192.90 and a 1-year high of $260.26. The company has a market cap of $11,811.70, a price-to-earnings ratio of 67.87, a PEG ratio of 1.89 and a beta of 0.61.
In other Cooper Companies news, CEO Robert S. Weiss sold 32,500 shares of the company’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $224.70, for a total value of $7,302,750.00. Following the completion of the transaction, the chief executive officer now directly owns 119,111 shares in the company, valued at approximately $26,764,241.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Allan E. Rubenstein sold 500 shares of the company’s stock in a transaction on Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total transaction of $111,000.00. Following the completion of the transaction, the director now owns 6,590 shares of the company’s stock, valued at $1,462,980. The disclosure for this sale can be found here. Insiders sold a total of 104,516 shares of company stock valued at $24,459,155 over the last 90 days. Company insiders own 1.60% of the company’s stock.
A number of equities research analysts recently commented on the stock. TheStreet lowered shares of Cooper Companies from a “b” rating to a “c” rating in a report on Thursday, March 8th. Cleveland Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Friday, February 9th. BMO Capital Markets reiterated an “outperform” rating and set a $280.00 price target (up from $277.00) on shares of Cooper Companies in a report on Friday, March 9th. Oppenheimer set a $265.00 price target on shares of Cooper Companies and gave the company a “hold” rating in a report on Friday, March 9th. Finally, Stephens reiterated a “hold” rating and set a $270.00 price target on shares of Cooper Companies in a report on Friday, March 9th. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Cooper Companies has an average rating of “Hold” and an average target price of $267.50.
TRADEMARK VIOLATION WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/03/14/5266-shares-in-cooper-companies-inc-coo-purchased-by-elkhorn-investments-llc.html.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.